Mark Dawdy
Family · Lees Summit, MONPI 1558147538
Payments from drug & device makers
Across 65 payments — averaging $18.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$234
- Lilly USA, LLC$173
- Novo Nordisk$166
- Lundbeck LLC$77
- AbbVie$71
- Antares Pharma, Inc.$54
- plus $423 from 17 others
What the payments were for
- Food & beverage$1,199100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 9 | $234 |
| Lilly USA, LLC | 11 | $173 |
| Novo Nordisk | 13 | $166 |
| Lundbeck LLC | 3 | $77 |
| AbbVie | 3 | $71 |
| Antares Pharma, Inc. | 3 | $54 |
| Pfizer | 3 | $53 |
| Viiv Healthcare Company | 2 | $40 |
| Phathom Pharmaceuticals, Inc. | 2 | $39 |
| Axsome Therapeutics, Inc. | 2 | $36 |
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
| Radius Health, Inc. | 1 | $30 |
| Ardelyx, Inc. | 1 | $21 |
| Viatris Specialty LLC | 1 | $20 |
| Scilex Pharmaceuticals Inc. | 1 | $20 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $19 |
| Alnylam Pharmaceuticals Inc. | 1 | $18 |
| Hologic Sales And Service, LLC | 1 | $17 |
| Organon | 1 | $17 |
| Merck | 1 | $16 |
| GSK | 1 | $16 |
| Amgen | 1 | $15 |
| Exact Sciences | 1 | $14 |
How this compares
$1,199 in reported general payments places this provider in the 70th percentile of 3,812 family providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 16 | $162 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 28 | $141 |
| Doxycycline Hyclate | 17 | $94 |
| Prednisone | 29 | $47 |
Paid to pharmacies, not to this prescriber.
Other family in Lees Summit
- Tamera WolfLees Summit$215K
- Crystal DavisonLees Summit$16K
- Christine HuntLees Summit$12K
- Connie SpencerSaint Joseph$320K
- Shayla SandersKansas City$306K
- Tiffany ArnoldFestus$177K
- Tiffany NelsonSedalia$164K
- Chelsey BeckerSaint Peters$104K
- Carey PattonDes Peres$94K
- Marcy MarkesColumbia$92K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.